Andrew Beck, PathAI CEO and co-founder

Glax­o­SmithK­line keeps truck­ing along­side AI with new, mul­ti-year pathol­o­gy part­ner­ship with Boston out­fit

Big Phar­ma has been in hot pur­suit of the al­lure of AI in­te­gra­tion, with the al­leged po­ten­tial for rev­o­lu­tion­iz­ing drug R&D. The UK’s Glax­o­SmithK­line has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.